Definitive Contract HHSN268200736195C
- Not listed
- This federal contract award is for the Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center, awarded by the National Heart Lung and Blood Institute, a civilian agency, to The Ohio State University Research Foundation. The contract is a definitive contract with a cost-no-fee pricing type and a ceiling value of $3,513,099.45. It does not have a set-aside designation. The Ohio State University Research Foundation is a U.S. state government entity and 1862 Land Grant College that...
- This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the University of Pittsburgh, a non-profit educational institution, for the "Long Term Oxygen Treatment Trial". The definitive cost-no-fee contract has a ceiling value of $2,552,564.24 and a completion date of June 30, 2016. The contract does not have a set-aside designation. The University of Pittsburgh, a major recipient of federal research funding, is serving as the...
- This federal contract award is for the Long Term Oxygen Treatment Trial, a research study funded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract, a Definitive Contract with cost-no-fee pricing, was awarded to The Johns Hopkins University, a private non-profit research university, on October 31, 2006, with a ceiling value of $15,824,931.90 and a completion date of April 30, 2017. The contract did not have a set-aside...
- This is a definitive contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to the Regents of the University of Michigan for the "Long Term Oxygen Treatment Trial" with a ceiling value of $2,882,600.31. The contract was awarded on October 31, 2006, with a final completion date of March 31, 2016. This contract was not set aside for any specific business type. Through past federal contracts and grants,...
- This is a definitive, firm fixed price contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the University of Washington. The contract, valued at $783,706.00, is for special studies and analysis services. The University of Washington has a history of delivering a range of services to federal agencies, including research and development work. This contract does not have a set-aside designation. The University of Washington also holds a separate $500...
- This is a $11,182,823.59 delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the University of Washington (UW) to serve as the Trans-Omics for Precision Medicine (TOPMed) Data Coordinating Center (DCC). The contract involves providing data coordination, specimen processing and distribution, quality control, and information management services to support research on atherosclerosis across diverse populations. The contract is not set...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Cost Plus Fixed Fee delivery order contract to the University of Washington for the MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED project. The contract has a potential value of $571,439.00 and a completion date of December 15, 2024. The contract does not have a set-aside designation. The University of Washington, a leading public research university, will provide...
- This is a firm fixed price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to the University of Washington. The contract is for $116,617.00 and has an ultimate completion date of September 29, 2017. The award is for a non-R&D project titled "IDENTIFYING COMMENSURATION BIAS IN NIH/CSR PEER REVIEW" and does not have a set-aside designation. The University of Washington is a leading...
- This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the University of Washington (UW) for the Trans-Omics for Precision Medicine (TOPMed) program's Centralized Omics Resource (CORE). The $3,849,872.50 firm fixed-price delivery order contract has a period of performance through September 22, 2026. The contract is not set aside and represents a component of UW's substantial IDIQ contract with NHLBI for the Multi-Ethnic Study of...
- This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 to the University of Washington for physician services to support lung transplant cases for VA Puget Sound Health Care System patients. The $1,285,406.12 contract has an ultimate completion date of March 31, 2017 and was awarded on October 1, 2015 with no set-aside designation. The University of Washington has a $500 million...
This is a definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the University of Washington (UW) for the Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center. The contract, which does not have a set-aside designation, has a ceiling value of $1,134,440.29 and runs through March 31, 2016. The LOTT is a major study focused on long-term oxygen treatment. As a Regional Clinical Center, UW is responsible for providing specialized medical research services to support this trial. UW is a prominent public research university with extensive expertise in biomedical research, including cardiovascular and respiratory disease studies. In addition to this LOTT contract, UW holds a significant $500 million indefinite delivery/indefinite quantity (IDIQ) contract with NHLBI for the Multi-Ethnic Study of Atherosclerosis (MESA) program, further demonstrating the agency's confidence in UW's scientific capabilities and data management services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 13 | Change Order | ($9k) | 3/24/17 | |
| 12 | Exercise an Option | $10.2k | 12/22/15 | |
| 11 | Funding Only Action | ($30k) | 9/25/15 | |
| 10 | Supplemental Agreement for work within scope | $60.8k | 12/16/14 | |
| 9 | Other Administrative Action | $0 | 11/1/13 |